Eichrom Technologies

About Eichrom Technologies

Eichrom Technologies is a Other / Uncategorized company; the kind of vendor BD teams should have a 15-minute conversation with at SNMMI.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• Endpoints News · 2026-04-21
  Eichrom Technologies signs supply agreement to support late-stage trials
  Coverage notes the company's growing footprint in the radioligand therapy space.
• Reuters Health · 2026-07-14
  Eichrom Technologies appoints new Chief Medical Officer ahead of pivotal trial
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
• BioPharma Reporter · 2026-10-07
  Eichrom Technologies announces Phase II readout for lead theranostic candidate
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• FierceBiotech · 2026-05-28
  Eichrom Technologies expands cyclotron capacity to meet Lu-177 demand
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.